Verhoogd risico op stress en stressgerelateerde klachten Stress tension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Study 1: In order to be eligible to participate in this study, a subject must meet all of the following criteria: The pregnant women should be >18 years of age, and
Exclusion criteria
Exclusion criteria: Study 1 A potential subject (pregnant woman) who meets any of the following criteria will be excluded from participation in this study: (1) chronic medical conditions such as Diabetes, (2) use of medication which is known to affect cardiovascular stress reactivity measures (e.g., * blockers), (3) substance abuse, (4) insufficient command of the Dutch language required to fill out questionnaires, (5) a score of 16 or higher on the depression scale of the HADS (cut-off score for severe depression), and (6) presence of a history of other severe mental disorders, such as Bipolar disorder or Schizophrenia.;If the partner of the pregnant woman meets any of the following criteria, the couple will be excluded from participation in this study: (1) presence of a history of other severe mental disorders, such as Bipolar disorder or Schizophrenia, (2) substance abuse, (3) insufficient command of the Dutch language required to fill out questionnaires.;Study 2 See exclusion criteria women of study 1.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numbering corresponds to numbering *Primary Objective* (a) Perceived stress and anxiety (pregnant women and their partners) assessed by means of self-report on validated questionnaires; stress physiology of parameters of the autonomic nervous system (e.g. heart rate, heart rate variability, pre-ejection period, respiratory sinus arrhythmia, skin conductance responses) as measured by basal functioning and by responses to a standardized stress task; (b) Medical complications during pregnancy; birth outcomes for the mother and child with regard to: gestational age, birth weight, APGAR scores (1-5 minutes), method of delivery, complications; (c) Infant behaviour and development: sleep patterns, feeding patterns, crying, infant temperament, motor and mental development. | — |
Secondary
| Measure | Time frame |
|---|---|
| Numbering corresponds to numbering *Secundary Objectives* (1) HRV-biofeedback parameters (related to changes in total blood volume). (2) Usability and validity of the DTI-2. (3) Diverted attention, using an emotional interference task. | — |
Countries
Netherlands